Vernakalant, Cardiome Limelight Could Make ARYx Glow
This article was originally published in The Pink Sheet Daily
Executive Summary
Amiodarone-derived, Phase II atrial fibrillation drug might prove even better, ARYx tells “The Pink Sheet” DAILY.
You may also be interested in...
Aryx’s Constipation Drug Boosts Bowel Function
Despite good results, GI agent takes back seat to firm’s promising late-stage heart drugs.
Aryx’s Constipation Drug Boosts Bowel Function
Despite good results, GI agent takes back seat to firm’s promising late-stage heart drugs.
Sanofi-Aventis Gets Priority Review For Second-Generation Atrial Fib Drug
Approval could come in early 2009 for Cordarone successor Multaq.